Head-to-head · WeighScore
Contour Health vs Fierce Health
The verdict
Contour Health takes it — 66.8/100 to 56.6/100.
Contour Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Contour Health (Desert Contour LLC) is a Utah-based telehealth provider offering compounded semaglutide and tirzepatide through a named 503A pharmacy partner, Strive Pharmacy.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Contour Health | Fierce Health |
|---|---|---|
| WeighScore | 66.8/100 | 56.6/100 |
| Grade | C | C |
| Scorecard rank | #177 | #410 |
| Semaglutide | $160/mo (starting dose, compounded) | $297/mo (3-month plan, compounded) |
| Tirzepatide | $300/mo (starting dose, compounded) | $497/mo (3-month plan, compounded) |
| Coverage | Coverage not published | 30 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Injection only |
Graded #177 · C
Strengths
- Free medical consultation — no charge to talk with a provider before starting
- Pay-per-vial pricing with no long-term subscription commitment required to participate
- Names its compounding pharmacy partner (Strive Pharmacy, 503A accredited) — a real transparency signal
- LegitScript badge links to a genuine, working LegitScript verification checker for the domain
- Board-certified Medical Director and named nurse-practitioner care team, not anonymous providers
Where it loses points
- State availability list is not published — Terms of Service only says "certain states"
- All product purchases are non-refundable per Terms of Service
- Compounded injectable only — no oral option, no brand-name Wegovy/Zepbound/Ozempic/Mounjaro
- Terms of Service also describe an optional subscription tier with a 3-month minimum, despite marketing emphasizing "no subscriptions"
- No insurance, Medicare, or Medicaid accepted — cash-pay or HSA/FSA only
Graded #410 · C
Strengths
- 30-state service list spelled out in the Terms — buyers can verify eligibility before intake
- LegitScript Certified
- Publishes the FDA compounded-medication disclaimer on every product page
- Four GLP-1 programs (standard and microdose semaglutide and tirzepatide) — a broader ladder than peers
- Microdose tier at $197/mo is one of the lower entry points we've seen
Where it loses points
- No named 503A compounding pharmacy partner — only generic 'partner pharmacies' language
- Operating LLC name not disclosed anywhere on the site
- Tirzepatide weight-loss program ($497/mo) showing 'sold out or unavailable' across all plans at review time
- Clinical provider network not named
- FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.